Beamtree Holdings Ltd

Cyan C3G Fund continues to hold its position in Beamtree Holdings Ltd, a rapidly growing global healthcare technology provider with software deployed in over 20 countries. The company has seen renewed investor interest, driven by its strong underlying results and the recent purchase of 20 million shares by Chairperson Emma Gray, increasing her personal ownership to 10.7% of the company. Beamtree has set a target of $60 million in annual recurring revenue by FY25, representing a compound annual revenue growth rate of 38% from FY23. Cyan C3G Fund is optimistic about the company's prospects, given its strong growth trajectory and the increasing importance of AI in its software solutions for the healthcare sector.

Cyan C3G Fund continues to hold Beamtree Holdings Ltd (BMT) despite a recent decline in performance following the announcement of CEO Tim Kelsey's departure in March 2025. While leadership change can raise concerns, the fund was reassured by the company’s FY25 Q1 Trading Update, which showed a 20% revenue growth for FY25 and confirmed its long-term target of reaching $60 million in annual recurring revenue (ARR) by the end of 2026 (up from $25.5 million as of June 2024). Given the positive revenue outlook and the company's long-term growth targets, Cyan C3G Fund remains optimistic about Beamtree's potential, viewing the temporary setback as part of its ongoing development.